We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

83 hedge funds and large institutions have $699M invested in Epizyme, Inc in 2014 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more call options, than puts

Call options by funds: $737K | Put options by funds: $314K

83% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 18

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

42% more capital invested

Capital invested by funds: $494M → $699M (+$205M)

11% more funds holding

Funds holding: 75 → 83 (+8)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
83
Holders Change
+8
Holders Change %
+10.67%
% of All Funds
2.39%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
20
Increased
33
Reduced
18
Closed
12
Calls
$737K
Puts
$314K
Net Calls
+$423K
Net Calls Change
+$362K

Top Buyers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
+$12.5M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$12.4M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$6.13M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.53M
5
SFM
Sphera Funds Management
Israel
+$2.67M

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$9.23M
2
NI
Numeric Investors
Massachusetts
-$5.87M
3
OM
Opaleye Management
Massachusetts
-$2.63M
4
SM
Sabby Management
Florida
-$2.41M
5
JP Morgan Chase
JP Morgan Chase
New York
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$2.3M – – –
Axa
27
Axa
France
$2.27M – – –
TCM
28
Tekla Capital Management
Massachusetts
$2.18M +$1.65M +70,162 New
Citigroup
29
Citigroup
New York
$2.08M -$9.23M -391,934 -85%
Millennium Management
30
Millennium Management
New York
$1.98M +$1.24M +52,479 +466%
BIM
31
BlackRock Investment Management
Delaware
$1.72M +$860K +36,526 +195%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.59M +$574K +24,355 +91%
TRSOTSOK
33
Teachers Retirement System of the State of Kentucky
Kentucky
$1.55M – – –
SM
34
Sabby Management
Florida
$1.52M -$2.41M -102,430 -68%
TCIM
35
TIAA CREF Investment Management
New York
$1.5M +$599K +25,448 +112%
Deutsche Bank
36
Deutsche Bank
Germany
$1.35M +$200K +8,494 +24%
PA
37
Perceptive Advisors
New York
$1.33M -$235K -10,000 -19%
HTHT
38
Hemenway Trust Hemenway Trust
New Hampshire
$965K -$212K -9,000 -23%
GACM
39
Green Arrow Capital Management
New York
$934K +$706K +30,000 New
FSA
40
Franklin Street Advisors
North Carolina
$874K -$4.71K -200 -0.7%
Charles Schwab
41
Charles Schwab
California
$861K +$241K +10,224 +59%
ProShare Advisors
42
ProShare Advisors
Maryland
$821K -$130K -5,511 -17%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$728K +$264K +11,200 +92%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$682K +$516K +21,900 New
TD Asset Management
45
TD Asset Management
Ontario, Canada
$644K +$487K +20,700 New
Macquarie Group
46
Macquarie Group
Australia
$622K – – –
DekaBank Deutsche Girozentrale
47
DekaBank Deutsche Girozentrale
Germany
$591K +$47.1K +2,000 +12%
TA
48
Teachers Advisors
New York
$565K -$1.09M -46,289 -72%
Morgan Stanley
49
Morgan Stanley
New York
$554K +$51.9K +2,204 +14%
Jane Street
50
Jane Street
New York
$534K +$404K +17,175 New
1
2
3 4

EPZM Hedge Fund Activity: Q2 2014 in Review

83 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q2 2014, worth a combined $699M — up 42% from $494M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new EPZM positions and 12 closed out — a net gain of 8 holders — while 33 added to existing stakes and 18 trimmed.

The largest buyer was QVT Financial, adding an estimated $12.5M. The largest seller was Citigroup, cutting an estimated $9.23M.

  • 83 institutional investors held Epizyme, Inc (EPZM) as of Q2 2014, up from 75 in Q1 2014.
  • Funds reported $699M of Epizyme, Inc stock for Q2 2014, up 42% quarter-over-quarter.
  • 20 funds opened new Epizyme, Inc positions in Q2 2014 and 12 closed out, a net change of +8 holders.
  • The largest Epizyme, Inc buyer in Q2 2014 was QVT Financial, an estimated $12.5M added.
  • The largest Epizyme, Inc seller in Q2 2014 was Citigroup, an estimated $9.23M sold.

Based on aggregated 13F filings for Q2 2014.